When activated by the alarmins or lipid mediators in vivo in mice, ILC2s can drive tissue eosinophilia independently of functional T cells, reflecting their potent productions of IL-5, IL-9, GM-CSF, IL-13, and, in some contexts, IL-4. The gene discussed is IL5; the disease is Increased total eosinophil count.